Betta Pharmaceuticals Co., Ltd.
- Country
- 🇨🇳China
- Ownership
- Joint Venture, Public, Subsidiary
- Established
- 2003-01-07
- Employees
- 1.9K
- Market Cap
- -
- Website
- https://www.bettapharma.com
Ensartinib as Adjuvant Treatment in Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer
- First Posted Date
- 2022-04-22
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 202
- Registration Number
- NCT05341583
- Locations
- 🇨🇳
TianJin Medical University Cancer Institute & Hospital, Tianjin, China
A Phase 1 Study of BPI-371153 in Subjects With Advanced Solid Tumors or Relapsed/Refractory Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2022-04-22
- Last Posted Date
- 2022-06-21
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 110
- Registration Number
- NCT05341557
- Locations
- 🇨🇳
Cangzhou Central Hospital, Cangzhou, Hebei, China
🇨🇳Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Chaoyang, Beijing, China
🇨🇳Tianjin Cancer Hospital, Tianjin, Tianjin, China
A Phase 1/2 Study of BPI-361175 in Subjects With Advanced Solid Tumors
- First Posted Date
- 2022-04-15
- Last Posted Date
- 2022-04-15
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 90
- Registration Number
- NCT05329298
- Locations
- 🇨🇳
Jiangsu Cancer Hospital, Nanjing, Jiangsu, China
🇨🇳Shanghai Pulmonary Hospital, Shanghai, Shanghai, China
🇨🇳Xiangya Hospital of Central South University, Changsha, Hunan, China
A Phase 1，Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors
- First Posted Date
- 2022-04-07
- Last Posted Date
- 2022-04-07
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT05315180
- Locations
- 🇨🇳
Wen Li, Ph.D, Hangzhou, Zhejiang, China
🇨🇳Yun Fan,Ph.D, Hangzhou, Zhejiang, China
🇨🇳Shun Lu, Ph.D, Shanghai, China
A Food-Effect Study of BPI-16350 in Healthy Subjects
- First Posted Date
- 2022-04-07
- Last Posted Date
- 2023-05-09
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT05316259
- Locations
- 🇨🇳
Kthics Committee (seal),of Beijing Youan Hospital,Capital Medical University, Beijing, Beijing, China
A Phase 1 Study of BPI-28592 in Subjects With Advanced Solid Tumors
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2022-03-31
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT05302843
- Locations
- 🇨🇳
Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang University School of Medicine, HangZhou, Zhejiang, China
Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2021-08-17
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT05007938
- Locations
- 🇨🇳
Feng Ye, Xiamen, Fujian, China
A Study of MRX2843 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
- First Posted Date
- 2021-07-01
- Last Posted Date
- 2021-07-01
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 104
- Registration Number
- NCT04946890
- Locations
- 🇨🇳
Junmin Li，Ph.D, Shanghai, Shanghai, China
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2021-06-18
- Last Posted Date
- 2021-12-21
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 400
- Registration Number
- NCT04930432
- Locations
- 🇨🇳
Guangdong Province Traditional Chinese Medical Hospital, Guangzhou, China
🇨🇳Cancer Hospital affiliated to Harbin Medical University, Ha'erbin, China
🇨🇳Qingdao Central Hospital, Qingdao, China
The Absorption, Metabolism and Excretion of [14C]D-0316 in Human
- Conditions
- Interventions
- First Posted Date
- 2020-07-09
- Last Posted Date
- 2021-06-02
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 4
- Registration Number
- NCT04464551
- Locations
- 🇨🇳
Jiangsu Province Hospital Affiliated to Nanjing Madical University of Medicine, Nanjing, Jiangsu, China